Abstract:Background: Hepatocellular carcinoma (HCC) is one of the most lethal cancers with a continuous increase in incidence. Drug resistance limits the therapeutic effects of multi-kinase inhibitor sorafenib for advanced stage HCC patients. Aberrant mitochondrial dynamics and metabolism now are considered as the hallmarks of tumor. Thus, we aimed to clarify the relationship between mitochondrial dynamics and metabolism, as well as explore the combination targeting therapies for sorafenib-resistant HCC.Methods: Mitochondrial morphology was evaluated by immunefluorescent staining. The switch of mitochondrial metabolism was evaluated by oxygen consumption ratio (OCR), glucose uptake and lactate production. The expression of Drp1 was determined by immunohistochemical staining, Western blot and real-time PCR. Cell counting, colony formation and cell cycle assays were performed to assess cell growth in vitro. In addition, time-lapse cell motility assay and transwell assay were used to evaluate cell migration and invasion capacities. The orthotopic xenograft models were used to illustrated the therapeutic effects of combinative administration of OXPHOS inhibitor IACS-010759 with Drp1 inhibitor mdivi-1.Results: In this study, Drp1-mediated mitochondrial fission and hyper-glycolytic phenotype were dominant in sorafenib-resistant HCC cells, which were closely correlated with tumor prognosis. Drp1 knockdown or inhibitor could impair the invasive and metastatic capacities, but promoted cell cycle and cellular growth, which was due to metabolic shift from aerobic glycolysis to oxidative phosphorylation (OXHOPS). Additional administration of OXPHOS inhibitor IACS-010759 combined with Drp1 inhibitor mdivi-1, alleviated the tumor progression of sorafenib-resistant HCC remarkably in both proliferation and metastasis.Conclusions: This study suggests that mitochondrial dynamics deeply influenced mitochondrial metabolism in sorafenib-resistant HCC cells, which exhibit more aggressive hybrid metabolic phenotype. Combination of targeting mitochondrial dynamics and metabolism may be an effective approach for overcoming sorafenib resistance of hepatocellular carcinoma.Funding: This work was supported by the Natural Science Foundation of Guangdong Province (1914050004928), Sanming Project of Medicine in Shenzhen (No. SZSM202011010) and Sanming Project of Medicine in Shenzhen (No. SZSM201911008).Declaration of Interest: All the authors declare no conflict of interest.Ethical Approval: The present study was performed abiding by the Helsinki Declaration and carried out under the approval of the Ethics Committee of Guangdong General Hospital.

Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1

Increased Mitochondrial Fission Promotes Autophagy and Hepatocellular Carcinoma Cell Survival Through the ROS-modulated Coordinated Regulation of the NFKB and TP53 Pathways

SIRT1 Facilitates Hepatocellular Carcinoma Metastasis by Promoting PGC-1α-mediated Mitochondrial Biogenesis.

Mitochondrial fission promotes cell migration by Ca 2+ /CaMKII/ERK/FAK pathway in hepatocellular carcinoma.

Mitochondrial Fission Forms a Positive Feedback Loop with Cytosolic Calcium Signaling Pathway to Promote Autophagy in Hepatocellular Carcinoma Cells

Drp1-mediated Mitochondrial Fission Promotes Cell Proliferation Through Crosstalk of P53 and NF-κB Pathways in Hepatocellular Carcinoma.

Advances in fatty acid metabolism reprogramming of lung cancer

Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis

Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation

Cancer-associated Fibroblasts Contributed to Hepatocellular Carcinoma Recurrence and Metastasis Via CD36-mediated Fatty-Acid Metabolic Reprogramming.

Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer–Initiating Cells

Acetyl-Coenzyme A Carboxylase Alpha Promotion of Glucose-Mediated Fatty Acid Synthesis Enhances Survival of Hepatocellular Carcinoma in Mice and Patients

Fatty Acid Transport Protein-5 (FATP5) Deficiency Enhances Hepatocellular Carcinoma Progression and Metastasis by Reprogramming Cellular Energy Metabolism and Regulating the AMPK-mTOR Signaling Pathway

Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling

Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma

Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells

Mitochondrial Fission-Induced Mtdna Stress Promotes Tumor-Associated Macrophage Infiltration and HCC Progression

Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC

The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis

Combination of Targeting Mitochondrial Dynamics and Metabolism Reverses the Acquired Resistance to Sorafenib in Hepatocellular Carcinoma

SIRT1/MRPS5 Axis Enhances the Metabolic Flexibility of Liver Cancer Stem Cells